Tenet Healthcare Corp (N:THC)
Business Focus: Healthcare Facilities & Services
Nov 19, 2024 08:00 am ET
Commure to Deploy Ambient AI Platform to Tenet Physician Resources for Enhanced Clinical Workflows
Commure, a leader in healthcare technology innovation, announced today that Tenet Healthcare Corporation (NYSE: THC), one of the nation’s largest healthcare providers, has selected Commure Scribe, an ambient AI platform, to be launched across its...
Oct 29, 2024 06:45 am ET
Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2024.
Oct 23, 2024 09:00 am ET
Tenet to Participate in the UBS Global Healthcare Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at 12:30 p.m. Eastern time.
Oct 02, 2024 09:00 am ET
Tenet to Report its Third Quarter 2024 Results on October 29th
Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2024 results before the market opens on Tuesday, October 29, 2024, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
Oct 01, 2024 06:45 am ET
Tenet Completes Sale of Five Hospitals in Birmingham
Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of its 70% majority ownership interest in Brookwood Baptist Health in Birmingham to Orlando Health consistent with previously disclosed terms.
Aug 15, 2024 09:00 am ET
Tenet to Participate in the 2024 Wells Fargo Healthcare Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, beginning at 9:30 a.m. Eastern time.
Aug 05, 2024 06:45 am ET
Tenet Healthcare to Sell Five Birmingham Hospitals to Orlando Health
Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Orlando Health for the sale of Tenet’s 70% majority ownership interest in Brookwood Baptist Health in Birmingham for approximately $910 million in cash (after-tax proceeds of approximately $790 million).
Jun 19, 2024 09:00 am ET
Tenet to Report its Second Quarter 2024 Results on July 24th
Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2024 results on Wednesday, July 24, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
May 01, 2024 08:00 am ET
Tenet to Participate in BofA Securities 2024 Health Care Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024, beginning at 12:20 p.m. Eastern time.
Apr 01, 2024 06:45 am ET
Tenet Completes Sale of Six Hospitals in California
Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of six hospitals and related operations in California consistent with previously disclosed terms.
Mar 28, 2024 08:00 am ET
Tenet to Report its First Quarter 2024 Results on April 30th
Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2024 results on Tuesday, April 30, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
Feb 29, 2024 06:45 am ET
Tenet to Sell Two Hospitals and Enter into a Revenue Cycle Services Partnership with Adventist Health
Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Adventist Health for the sale of two Tenet hospitals and related operations in San Luis Obispo County. Tenet also announced its Conifer Health Solutions subsidiary will enter into an agreement to provide revenue cycle services for Adventist Health.
Feb 21, 2024 09:00 am ET
Tenet to Participate in Barclays 26th Annual Global Healthcare Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays Global Healthcare Conference on Tuesday, March 12, 2024, beginning at 9:30 a.m. Eastern time.
Feb 16, 2024 05:00 pm ET
Tenet Calls for Full Redemption of 4.875% Senior Secured First Lien Notes due 2026
Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all $2,100 million outstanding of its 4.875% Senior Secured First Lien Notes due 2026 (the “Notes”), which were issued pursuant to the Indenture, dated as of November 6, 2001 (the “Base Indenture”), by and between Tenet and The Bank of New York, as predecessor to The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the Thirty-Second Supplemental Indenture, dated as of August 26, 2019 (the “Thirty-Second Supplemental Indenture” and, the Base Indenture, as amended and supplemented by the Thirty
Feb 08, 2024 06:30 am ET
Tenet Reports Fourth Quarter and FY 2023 Results; Provides 2024 Financial Outlook
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter and year ended December 31, 2023.
Feb 01, 2024 06:45 am ET
Tenet Advances Portfolio Transformation and Previews Strong 2023 Results
Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of three of its hospitals and related operations in South Carolina to Novant Health for approximately $2.4 billion. Tenet also announced it has entered into a definitive agreement with UCI Health for the sale of four Tenet hospitals and related operations in Orange County and Los Angeles County, California for approximately $975 million in cash. In addition, Tenet announced that it expects to exceed the high end of its latest FY23 Adjusted EBITDA Outlook range included in its third quarter 2023 earnings rel
Feb 01, 2024 06:00 am ET
UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation
Acquisition of Tenet's Pacific Coast Network would expand unrestricted to healthcare for Orange County and beyond
Jan 09, 2024 09:00 am ET
Tenet to Report its Fourth Quarter 2023 Results on February 8th
Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2023 results on Thursday, February 8, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
Dec 13, 2023 04:05 pm ET
Tenet Healthcare Appoints Vineeta Agarwala to Board of Directors
Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors.
Nov 17, 2023 06:45 am ET
Tenet Healthcare to Sell Three South Carolina Hospitals to Novant Health
Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Novant Health for the sale of three Tenet hospitals and related operations in South Carolina for approximately $2.4 billion in cash (after-tax proceeds of approximately $1.750 billion).
Nov 17, 2023 06:00 am ET
Novant Health to acquire three hospitals from Tenet Healthcare
Acquisition by Novant Health of Tenet hospitals and affiliated operations will bring expanded access to high-quality care in South Carolina
Oct 30, 2023 04:05 pm ET
Tenet Reports Third Quarter 2023 Results; Raises 2023 Outlook
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2023.
Oct 09, 2023 09:00 am ET
Tenet to Report its Third Quarter 2023 Results on October 30th
Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2023 results after the market closes on Monday, October 30, 2023, to be followed by a conference call at 4:00 p.m. CT (5:00 p.m. Eastern Time).
Sep 18, 2023 08:10 am ET
Tenet Healthcare Streamlines HR and Payroll Processes with Oracle
Leading health system and services platform selects Oracle Cloud HCM to automate manual processes and improve user experience
Aug 10, 2023 04:05 pm ET
Tenet Healthcare Appoints Senator Roy Blunt to Board of Directors
Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members.
Aug 10, 2023 06:45 am ET
Tenet Healthcare Names CEO Saum Sutaria as Chairman of the Board
Tenet Healthcare Corporation (NYSE: THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022.
Jul 31, 2023 04:05 pm ET
Tenet Reports Second Quarter 2023 Results; Raises 2023 Outlook
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended June 30, 2023.
Jul 11, 2023 09:00 am ET
Tenet to Report its Second Quarter 2023 Results on July 31st
Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2023 results after the market closes on Monday, July 31, 2023, to be followed by a conference call at 4:00 p.m. CT (5:00 p.m. Eastern Time).
Jun 23, 2023 06:45 am ET
Tenet Announces Chief Financial Officer Transition
Tenet Healthcare Corporation (NYSE: THC) announced the appointment of Sun Park as Executive Vice President & Chief Financial Officer of the Company, effective January 1, 2024, as part of the Company’s planned Chief Financial Officer transition. Mr. Park will serve as an Executive Vice President of the Company from July 11, 2023 through December 31, 2023.
May 31, 2023 08:00 am ET
Tenet to Participate in 44th Annual Goldman Sachs Global Healthcare Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 44th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 13, 2023, beginning at 9:20 a.m. Pacific time (12:20 p.m. Eastern Time).
May 30, 2023 04:05 pm ET
Tenet Announces Appointment of Stephen H. Rusckowski to Board of Directors
Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Stephen H. Rusckowski to the Tenet Board of Directors, effective immediately. Rusckowski will serve as a member of the human resources committee and quality, compliance, and ethics committee. This appointment expands the Board to 11 directors, 10 of whom are independent members.
May 02, 2023 05:09 pm ET
Tenet Calls for Full Redemption of 4.625% Senior Secured First Lien Notes due 2024
Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all $756 million outstanding of its 4.625% senior secured first lien notes due July 2024 (the “July 2024 Notes”), which were issued pursuant to the Indenture, dated as of November 6, 2001, by and between Tenet and The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York (the “Base Indenture”), as supplemented by the Twenty-Ninth Supplemental Indenture, dated as of July 14, 2017, and all $589 million outstanding of its 4.625% senior secured first lien notes due September 2024 (the “S
May 02, 2023 05:06 pm ET
Tenet Announces Pricing of its $1.350 Billion Private Offering of Senior Secured Notes
Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.350 billion in aggregate principal amount of senior secured first lien notes due on May 15, 2031, which will bear interest at a rate of 6.750% per annum (the “notes”). Completion of the notes offering is expected to occur on May 16, 2023, and is subject to, among other things, customary closing conditions.
May 02, 2023 08:22 am ET
Tenet Announces $1.350 Billion Private Offering of Senior Secured Notes
Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.350 billion in aggregate principal amount of new senior secured first lien notes maturing in 2031 (the “notes”). Completion of the notes offering is subject to, among other things, pricing and customary closing conditions.
Apr 27, 2023 09:00 am ET
Tenet to Participate in BofA Securities 2023 Health Care Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2023 Health Care Conference in Las Vegas, NV, on Tuesday, May 9, 2023, beginning at 9:20 a.m. Pacific time (12:20 p.m. Eastern Time).
Apr 25, 2023 06:45 am ET
Tenet Reports First Quarter 2023 Results; Raises 2023 Outlook
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2023.
Apr 03, 2023 09:00 am ET
Tenet to Report its First Quarter 2023 Results on April 25th
Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2023 results before the market opens on Tuesday, April 25, 2023, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
Feb 23, 2023 09:00 am ET
Tenet to Participate in Barclays Global Healthcare Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2023, beginning at 9:30 a.m. Eastern time.
Feb 09, 2023 06:45 am ET
Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2022.
Feb 08, 2023 06:00 pm ET
USPI and Providence Expand Partnership with a New Development Agreement
United Surgical Partners International (USPI), the largest ambulatory surgery platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and Providence, a not-for-profit health system serving the Western U.S., announced today that they have signed a new development agreement that will increase access to ambulatory surgical services across many communities.
Jan 30, 2023 12:00 pm ET
USPI Facilities Recognized for Excellence in Patient Experience
United Surgical Partners International (USPI), a subsidiary of Tenet Healthcare Corporation (NYSE: THC), announced today that 24 facilities were recognized by Press Ganey for excellence in patient experience.
Jan 19, 2023 06:45 am ET
Tenet Anticipates Beating Midpoint of Latest 2022 Outlook; Announces Key Leadership Updates
Tenet Healthcare Corporation (Tenet) (NYSE: THC) announced today that it expects to exceed the midpoint of its latest FY22 Adjusted EBITDA Outlook range included in its third quarter 2022 earnings release along with key leadership updates that will help support long-term business performance.
Jan 17, 2023 09:00 am ET
Tenet to Report its Fourth Quarter 2022 Results on February 9th
Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2022 results on Thursday, February 9, 2023, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).
Nov 15, 2022 09:00 am ET
Tenet to Participate in BofA Securities 2022 Leveraged Finance Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2022 Leveraged Finance Conference on Tuesday, November 29, 2022, beginning at 8:10 a.m. Eastern time.
Oct 24, 2022 09:00 am ET
Tenet to Participate in Credit Suisse Healthcare Conference
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022, beginning at 11:00 a.m. Eastern time.
Oct 20, 2022 04:05 pm ET
Tenet Reports Third Quarter 2022 Results; Announces $1 Billion Share Repurchase Program
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2022.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.